Transvaginal laser therapy for urogenital atrophy: interventional procedure consultation
We are listening to your views on this interventional procedures guidance. Comments close 12 February 2021.
Search results
654 results
-
-
Laser lithotripsy for difficult-to-treat bile duct stones: interventional procedure consultation
We are listening to your views on this interventional procedures guidance. Comments close 12 February 2021.
-
Transvaginal laser therapy for stress urinary incontinence: interventional procedure consultation
We are listening to your views on this interventional procedures guidance. Comments close 12 February 2021.
-
Ex-situ machine perfusion for extracorporeal preservation of lungs (ex - vivo lung perfusion) for transplantation: interventional procedure consultation
We are listening to your views on this interventional procedures guidance. Comments close 12 February 2021.
-
Anakinra for treating active Stills disease [ID1463]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 27 January 2021.
-
Nivolumab for treating squamous cell carcinoma of the head and neck after platinum-based chemotherapy (CDF Review TA490) [ID1585]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 28 January 2021.
-
Chlormethine gel for treating mycosis fungoides-type cutaneous T-cell lymphoma [ID1589]: appraisal consultation
We are listening to your views on this technology appraisal guidance. Comments close 11 February 2021.
-
Velmanase alfa for treating alpha-mannosidosis [ID800]
In development [GID-HST10010] Expected publication date: TBC
-
Human alpha1-proteinase inhibitor for treating emphysema ID856
In development [GID-HST10017] Expected publication date: TBC
-
Lysosomal acid lipase deficiency - sebelipase alfa [ID737]
In development [GID-LYSOSOMALACIDLIPASEDEFICIENCYSEBELIPASEALFAID737] Expected publication date: TBC
-
Afamelanotide for treating erythropoietic protoporphyria [ID927]
In development [GID-HST10009] Expected publication date: TBC
-
Onasemnogene abeparvovec for treating spinal muscular atrophy type 1 [ID1473]
In development [GID-HST10026] Expected publication date: 25 March 2021
-
Palovarotene for preventing heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID3739]
In development [GID-HST10032] Expected publication date: TBC
-
Palovarotene for treating flare ups of heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID2721]
In development [GID-HST10033] Expected publication date: TBC
-
OTL-200 for treating metachromatic leukodystrophy [ID1666]
In development [GID-HST10028] Expected publication date: 13 August 2021
-
Givosiran for treating acute hepatic porphyria [ID1549]
In development [GID-HST10035] Expected publication date: 04 August 2021
-
Elosulfase alfa for treating mucopolysaccharidosis type IVa (review of HST2) [ID1643]
In development [GID-HST10027] Expected publication date: TBC
-
Metreleptin for treating lipodystrophy (ID861)
In development [GID-HST10011] Expected publication date: 24 February 2021
-
The MAGEC system for spinal lengthening in children with scoliosis
In development [GID-MT544] Expected publication date: 15 September 2020
-
SpaceOAR hydrogel spacer for reducing rectal toxicity during radiotherapy for prostate cancer (Suspended – referred to technology appraisals)
In development [GID-MT526] Expected publication date: TBC
-
DHT pilot: myCOPD for self-management of chronic obstructive pulmonary disease (COPD)
In development [GID-MT531] Expected publication date: TBC
-
Synergo for non-muscle-invasive bladder cancer
In development [GID-MT553] Expected publication date: TBC
-
MT582 AnaConDa
In development [GID-MT556] Expected publication date: 23 February 2022
-
Sleepio for adults with difficulty sleeping (MT443)
In development [GID-MT552] Expected publication date: 03 August 2021
-
Prontosan for acute and chronic wounds
In development [GID-MT551] Expected publication date: 05 October 2021
-
Alpha Stim AID (MT477)
In development [GID-MT542] Expected publication date: 08 March 2021
-
V.A.C. VERAFLO Therapy System for acute infected or chronic wounds that are failing to heal (MT471)
In development [GID-MT543] Expected publication date: 27 January 2020
-
Leukomed Sorbact for preventing surgical site infection (MT496)
In development [GID-MT541] Expected publication date: 03 February 2021
-
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (MT241)
In development [GID-MT548] Expected publication date: 04 May 2021
-
Endo-SPONGE for treating low rectal anastomotic leakage (MT461)
In development [GID-MT539] Expected publication date: TBC
-
Peezy Midstream for urine collection (MT446)
In development [GID-MT538] Expected publication date: TBC
-
GID-MT557 Novii Wireless Patch System for maternal and fetal monitoring (MT509)
In development [GID-MT557] Expected publication date: 22 March 2022
-
DyeVert for reducing contrast media in coronary and peripheral angiography (MT488)
In development [GID-MT550] Expected publication date: 04 October 2021
-
GID-MT554 KardiaMobile for the ambulatory detection of atrial fibrillation
In development [GID-MT554] Expected publication date: 06 January 2022
-
3C Patch System for treating diabetic foot ulcers (MT539)
In development [GID-MT559] Expected publication date: 19 January 2022
-
Danis Stent for acute oesophageal variceal bleeds (MT450)
In development [GID-MT537] Expected publication date: 25 May 2021
-
MT507 Plus Sutures for preventing surgical site infection (MIB204)
In development [GID-MT558] Expected publication date: 09 November 2021
-
Atezolizumab monotherapy for untreated PD-L1 positive metastatic non-small-cell lung cancer [ID1678]
In development [GID-TA10587] Expected publication date: 02 June 2021
-
Nivolumab with ipilimumab and chemotherapy for untreated advanced non-small-cell lung cancer [ID1566]
In development [GID-TA10472] Expected publication date: 02 June 2021
-
Epilepsies in children, young people and adults
In development [GID-NG10112] Expected publication date: 16 November 2021
-
Epilepsies in adults: diagnosis and management update (Please see Epilepsies in children, young people and adults)
In development [GID-NG10110] Expected publication date: TBC
-
Type 2 diabetes in adults: management (update)
In development [GID-NG10160] Expected publication date: TBC
-
Diabetes update
In development [GID-NG10152] Expected publication date: TBC
-
Cardiovascular disease: risk assessment and reduction, including lipid modification
In development [GID-NG10178] Expected publication date: 19 April 2023
-
Type 1 diabetes in adults: diagnosis and management (update)
In development [GID-NG10159] Expected publication date: TBC
-
Shared decision making
In development [GID-NG10120] Expected publication date: 17 June 2021
-
Safe prescribing and withdrawal management of prescribed drugs associated with dependence and withdrawal
In development [GID-NG10141] Expected publication date: 17 November 2021
-
Multiple sclerosis in adults: management
In development [GID-NG10153] Expected publication date: 20 July 2022
-
Pernicious anaemia
In development [GID-NG10176] Expected publication date: 23 March 2023
-
Acne Vulgaris: Management
In development [GID-NG10109] Expected publication date: 09 June 2021